Happy Thanksgiving week, everyone! The market’s much-needed strong start to this holiday-shortened week is certainly something to be thankful for in the midst of what has mostly been a rough November, particularly for growth investors. Maybe today’s run-up will spark a turnaround. In case there are more wild gyrations ahead, however, today we add a low-beta, way-undervalued utility stock that I recommended to my Cabot Value Investor audience earlier this month. We could use a couple more defensive positions as the market has become more risk-off, and this stock certainly qualifies.

Details inside.

It was another rocky week for the market as the tone was set by a rotation out of richly valued tech names, worries over whether the Federal Reserve would stay on hold rather than cut interest rates, and the big story was ongoing concerns about the sustainability of the AI-driven rally. By week’s end the S&P 500 and Dow had lost 2%, while the Nasdaq fell 3.2%.

It was another rocky week for the market as the tone was set by a rotation out of richly valued tech names, worries over whether the Federal Reserve would stay on hold rather than cut interest rates, and the big story was ongoing concerns about the sustainability of the AI-driven rally. By week’s end the S&P 500 and Dow had lost 2%, while the Nasdaq fell 3.2%.

*Note: Your next issue of Cabot Explorer will arrive next Wednesday, November 26 due to the market holiday next Thursday, November 27 in observance of Thanksgiving Day.

Nvidia (NVDA) sales in the October quarter hit a record $57 billion as demand for the company’s advanced Blackwell AI data center chips continued to surge, up 62% from the year-earlier quarter and beating consensus estimates. This should keep AI momentum moving forward.

By coincidence, Saudi Arabia’s Crown Prince Mohammed bin Salman’s (MBS) high level visit to Washington this week led to the Commerce Department approving sales of substantial advanced chips to Saudia Arabia as well as a slew of related deals. My question is whether these deals are investing in Saudi’s economic transformation rather than in American jobs, technology, and growth.

The market continues to be on edge but having lightened up over the last two and a half months we’re in a decent position to add some exposure today.

This month’s issue offers fresh opportunities in the red-hot pharma space, as well as two little-known mid-cap industrial stories, one in radiation protection and the other in the oil and gas market. Wrapping things up is an introduction to what’s arguably the best play on utility-scale solar.

Enjoy!

Before we dive into this week’s idea we need to move on from our Applied Digital (APLD) covered call as the stock has come under intense selling pressure as the AI story has weakened.

It doesn’t take a proprietary market timing system to see that the evidence has been weakening during the past few weeks—and especially during the past two weeks. That said, the major indexes have refused to give it up, with the big-cap indexes holding near their 50-day lines and, frankly, with more than a few high-relative-strength stocks holding in there. Even so, given the selling, we think it’s best to stay close to shore right now: We’ve moved our Market Monitor to a level 4, which isn’t a sign to sell wholesale, but to limit new buying in general while tightening stops and holding a good amount of cash.

This week’s list surprisingly still has a lot of resilient growth names, which we continue to find interesting given the selling that’s been going on. Our Top Pick is a well-sponsored medical firm with solid growth and a powerful recent breakout.

The market has gotten a lot bumpier in November, though the major indexes haven’t given up much ground. That’s because even as the air comes out of the (perhaps overinflated) artificial intelligence balloon of late, investors are instead rotating into the many under-loved names in other sectors. Today, we add a stock in one of those underappreciated sectors. It’s an educational company that Carl Delfeld recommended to his Cabot Explorer audience last month. And the stock is having a solid year.

Details inside.

Despite a frantic week of heavy sector rotation, the indexes managed to hang in there. Essentially, lofty tech valuations in the AI and growth spaces are now in question, and that hot money poured into defensive sectors. In the end, the S&P 500 eked out a +0.08% gain, the Dow rose +0.34%, and the Nasdaq Composite lost -0.45% last week.

Despite a frantic week of heavy sector rotation, the indexes managed to hang in there. Essentially, lofty tech valuations in the AI and growth spaces are now in question, and that hot money poured into defensive sectors. In the end, the S&P 500 eked out a +0.08% gain, the Dow rose +0.34%, and the Nasdaq Composite lost -0.45% last week.

The market’s evidence has clearly worsened the past two weeks and, really, there hasn’t been any money made in growth stocks since late September, when more names began to flash abnormal action and crack. We’ve mostly been selling in recent weeks, building up a big cash position of 56%, and tonight we’re hanging on to that as our Cabot Tides is on the fence, Two-Second Indicator is negative and many stocks are headed south. To be fair, the indexes are hanging in there and we still have many stocks we like (we write about some liquid biopsy stocks and other potential leaders in tonight’s issue), so we’re staying flexible--but right now it’s prudent to hold our cash and see how this selling wave plays out.

Hopefully, by the time you read this, the government shutdown will be over (at least for a couple of months). It’s about time! I was lucky on my trip to Florida a couple of weeks ago that I only sat on the tarmac for two hours, as things certainly have become much worse for travelers around the country since then.

Who knows if Congress will work out the kinks by January, but at least it’s some progress.

In her latest State of the Union address, European Commission President Ursula von der Leyen provided the parliament and citizens of Europe with a stark reminder of a problem that continues to plague governments, corporations and individuals around the world.

In her speech, she specifically referenced “the higher cost of living” for millions of Europeans as “THE global crisis” (emphasis mine). Not climate or geopolitical instability or cybersecurity threats, but inflation.

Small caps continue to underperform large caps in 2025.

The S&P 600 is up a mere 3.6% year to date, trailing the S&P 500’s 16.7% gain by roughly 13 percentage points.

The gap closes meaningfully if we strip out megacaps’ strong performance and compare the S&P 600 with the S&P 500 Equal Weight ETF (RSP), which is up “just” 10.3%.

The end of the government shutdown is buoying markets while indications that some of the AI-related stocks are retrenching is a headwind for the overall market.

The AI story is clearly impacting the cutting of management jobs with the worst numbers in one month in more than two decades, according to outplacement firm Challenger, Gray & Christmas. The last time companies made more layoffs during that month was in 2003, when cell phones started to take off. American investors funded $104 billion of AI startups in the first half of 2025 alone.

Growth stocks, led by the Magnificent Seven, have again carried the market this year.

The Mag. 7 – the clever name for big-tech behemoths Amazon (AMZN), Apple (AAPL), Google (GOOG), Meta (META), Microsoft (MSFT), Nvidia (NVDA) and Tesla (TSLA) – are up an average of 22% this year. Because those seven companies account for more than a third of the entire S&P 500, they’ve carried the index to a solid 16.5% gain year to date. The Equal Weight S&P 500 index, which equally weighs each of the 500 stocks that comprise the benchmark index, is up a mere 8.5% and has barely budged since the Fourth of July. For most stocks, the entirety of this year’s rally occurred during the post-Liberation Day run-up from the second half of April through early July.

It’s cannabis earnings season once again. Like most retailers, cannabis companies report late in the earnings season. I’ll get into company details below. But first, here are the key sector takeaways from third-quarter results.

Stocks started off this week much higher as the end of the government shutdown seems likely. The newfound strength comes off a sluggish month for stocks and could signal a new surge higher.

The shutdown has lasted over 40 days, and investors began to worry that it was negatively affecting consumer confidence and could lower GDP going forward. Ending the shutdown does take some risk off the table. At the same time, some bullish forecasts have come out for 2026, citing rising overall earnings and continuing AI dominance.

In view of the alarming number of news headlines that point to a weakening economy (at least in some quarters of it), it may seem surprising that the normally defensive consumer staple stocks are underperforming.

Normally, the staples are viewed by investors as something of a safe haven during periods of economic uncertainty, providing as they do essential goods like food and household products that are purchased even in tough times. But the present environment is proving to be an exception to that rule of thumb.

WHAT TO DO NOW: Our Cabot Tides are now on the fence while our Two-Second Indicator is negative as the market is in the middle of another test of the uptrend. Meanwhile, growth stocks have bent but not too many have truly broken, and there are still a good number setups out there. We sold Arista (ANET) on a special bulletin this morning, leaving us with around 45% in cash; we’ll hold onto that tonight as we want to see how this pullback plays out. Details below.

After beautifully navigating the historically troubling months of September and October, stocks are off to a dicey start this month. While the S&P managed to close slightly higher on Monday, most stocks had a rotten day. The index was propelled by technology while 400 of the 500 stocks moved lower on the day. On Tuesday, technology sold off and almost all sectors were lower. Is this a hiccup or a harbinger?

The S&P 500 started the week on another up note. But the index return is deceiving.

The S&P is being pulled higher by a handful of technology stocks. But 400 of the 500 stocks and nine of the 11 sectors were lower on Monday at midday. The earnings season so far has reaffirmed a positive outlook for artificial intelligence investments. That helps drive the index higher as technology stocks represent more than a third.

It’s not always that the market outperforms in October, but this year’s “jinx month” came and went on a positive note (albeit with a minor setback earlier in the month).


Granted, there was some volatility on the political front, but as far as the equity market was concerned, it wasn’t too bad. The S&P 500 index stood at a record high as recently as Wednesday, and Wall Street’s favorite stocks and ETFs are mainly trending higher as we exit the month.

The Russell 2000 and S&P 600 SmallCap Index have pulled back from recent highs, but the data suggests they’ll go higher in the weeks ahead.

Bank of America’s seasonality analysis shows November tends to be a strong month for the market. The Russell 2000 is up 70% of the time, with an average gain of 2.64%. Small-cap industrials tend to be particularly strong, up by 6.1% on average, and rising 79% of the time.

Today, a whopping eight Profit Booster positions will expire. Most are “slam-dunk,” full-profit trades, while others will go down to the wire.

The big takeaway, before we dive in, is we are going to let the situation play itself out, and come Monday/Tuesday of next week we will revisit our profits, as well as how we will manage the remaining positions.

Sell Warrior Met Coal (HCC). Buy Second Half of Life360 (LIF)

Lighten up a Little

WHAT TO DO NOW: The market remains very mixed, as we continue to see some tempting names but also more than a few that are hitting potholes, as well as rotation into safe areas. Yesterday, we sold Life360 (LIF) after that stock fell apart on earnings—and now we’re going to sell our half-sized stake in AppLovin (APP), with Friday’s and Monday’s encouraging action going up in smoke since. That will leave us with a high-50% cash position, which is a lot; if the market stabilizes, we’ll probably start a couple of new positions, but for the moment we’ll sit with that cash and see how things play out.

WHAT TO DO NOW: The market has bounced back decently, though our market timing indicators are still looking iffy for now. Today’s bulletin is about Life360 (LIF), which is falling hard today despite a solid quarterly report. Given the abnormal action, we’re forced to sell and take what’s left of our profit. Our cash position will now be around 50%.

Life360 (LIF) Delivers Q3 Report

I plan on locking in returns on several of our current positions and immediately selling more premium. In addition, I plan to add at least one more stock to the portfolio, which will bring our total to seven stocks. I also intend on continuing to ladder our positions in perpetuity, so we are collecting premium on a weekly basis. As it stands, we have positions due to expire over the next four consecutive weeks.



Other than that, there really isn’t much to say at the moment. We continue to be pleased with the overall mechanics of our approach and more importantly the overall return, which currently stands at 145.7%.

Options trading has its own vernacular. To know how to do it, you need to know what every options term means. Here are some of the basics.

Relatively new in the investing space, yieldcos give income investors a great way to participate in the renewable energy market.

Want to know how the big institutional investors use options? Here is an example of how one trader spent $132 million on three technology stocks.

Anytime we do a bit of spring cleaning in the portfolio—like the round prompted by February’s correction—I like to review our rules for selling.

Cabot Stock of the Week is a great way to build a diversified portfolio of the top growth, undervalued, momentum, international, dividend and small-cap stocks selected for current market conditions from seven Cabot investment advisories.

Applying principles from Benjamin Graham, Warren Buffett and other top value investors to bring you the bast value candidates.

Here are 10 of the soundest rules, tools and principles for selling winning stocks.

Cabot Top Ten Trader is meant to be something where we do the first four or five steps of the process for you and then let you take it from there.

I explore how to build a reasonably diversified portfolio based on a value investment approach.

Here’s a step-by-step guide to investing with the Cabot Benjamin Graham Value Investor.